World's Best Scientists 2026 revealed!
Hanneke Schuitemaker

Hanneke Schuitemaker

Award Badge
Immunology
Austria
2026
Award Badge
Immunology
Belgium
2025

D-Index & Metrics

Immunology

D-Index
100
Citations
38589
World Ranking
724
National Ranking
5

Medicine

D-Index
100
Citations
38589
World Ranking
8253
National Ranking
42

Research.com Recognitions

  • 2026 - Research.com Immunology in Austria Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award

Overview

Hanneke Schuitemaker is affiliated with Janssen (Belgium) and has conducted extensive research primarily in the field of medicine, with a strong focus on infectious diseases. Their work encompasses various domains such as epidemiology, virology, genetics, and molecular biology.

The scientist's main research topics include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Virus-based gene therapy research
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 detection and testing

Schuitemaker has published numerous papers, often collaborating with several frequent co-authors such as Dan H. Barouch, Roland Zahn, Frank Wegmann, Mathieu Le Gars, and Macaya Douoguih. Their research findings have appeared in a range of scientific journals.

Notable recent papers include:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine, 2021, New England Journal of Medicine
  • Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques, 2020, Nature
  • Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses, 2020, npj Vaccines
  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans, 2021, Nature

Frequent publication venues for Schuitemaker's work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Vaccines
  • Nature Communications
  • The Journal of Infectious Diseases
  • New England Journal of Medicine

Schuitemaker's contributions span over a hundred publications related to infectious diseases, with a particular emphasis on SARS-CoV-2 and COVID-19 research. Their involvement in vaccine development is reflected in studies of the Ad26.COV2.S vaccine, which appears prominently among their publications. This research highlights aspects such as safety, efficacy, immunogenicity, and protective effects of vaccine candidates against COVID-19.

Best Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

    H Schuitemaker;M Koot;N A Kootstra;M W Dercksen

  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.

    Jerald Sadoff;Mathieu Le Gars;Georgi Shukarev;Dirk Heerwegh

  • A new classification for HIV-1

    E. A. Berger;R. W. Doms;E.-M. Fenyö;B. T. M. Korber

  • Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.

    R A Fouchier;M Groenink;N A Kootstra;M Tersmette

  • Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

    Noe B. Mercado;Roland Zahn;Frank Wegmann;Carolin Loos;Carolin Loos

  • Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

    M R Klein;C A van Baalen;A M Holwerda;S R Kerkhof Garde

  • Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

    A B van't Wout;N A Kootstra;G A Mulder-Kampinga;N Albrecht-van Lent

  • Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.

    Hugo Mouquet;Louise Scharf;Zelda Euler;Yan Liu

  • T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

    Mette D. Hazenberg;Dörte Hamann;Hanneke Schuitemaker;Frank Miedema

  • Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

    Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield

  • Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.

    H. Schuitemaker;N. A. Kootstra;R. E. Y. De Goede;F. De Wolf

  • In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.

    Hetty Blaak;Angélique B. van't Wout;Margreet Brouwer;Berend Hooibrink

  • Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data

    J. P.A. Ioannidis;P. S. Rosenberg;J. J. Goedert;L. J. Ashton

  • Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection

    A.M. de Roda Husman;M. Koot;M.T.E. Cornelissen;I.P.M. Keet

  • A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

    Anders Krarup;Daphné Truan;Polina Furmanova-Hollenstein;Lies Bogaert

  • Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized Clinical Trial

    Iain D. Milligan;Malick M. Gibani;Richard Sewell;Elizabeth A. Clutterbuck

  • Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

    Unknown

  • Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.

    Lisa H. Tostanoski;Frank Wegmann;Amanda J. Martinot;Amanda J. Martinot;Carolin Loos;Carolin Loos

  • Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

    Dan H. Barouch;Dan H. Barouch;Kathryn E. Stephenson;Erica N. Borducchi;Kaitlin Smith

  • Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes

    Steven W. de Taeye;Gabriel Ozorowski;Alba Torrents de la Peña;Miklos Guttman

  • Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.

    Amy W. Chung;Amy W. Chung;Manu P. Kumar;Kelly B. Arnold;Wen Han Yu;Wen Han Yu

Frequent Co-Authors

Neeltje A. Kootstra
Neeltje A. Kootstra University of Amsterdam
Frank Miedema
Frank Miedema Utrecht University
Dan H. Barouch
Dan H. Barouch Harvard Medical School
Rogier W. Sanders
Rogier W. Sanders University of Amsterdam
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Jan M. Prins
Jan M. Prins University of Amsterdam
Suzanne Jurriaans
Suzanne Jurriaans University of Amsterdam
Ronald P. van Rij
Ronald P. van Rij Radboud University
Jean-François Zagury
Jean-François Zagury heSam Université

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare and research careers. For those interested in the clinical aspect, exploring the best online pmhnp programs can be a great way to advance into psychiatric nursing with strong clinical training. These programs often offer excellent placement rates, ensuring practical experience alongside theoretical knowledge.

Cost is a significant factor for many students. To find budget-friendly options, consider the cheapest online pmhnp certificate programs that balance affordability with quality education. This can make specialized nursing degrees more accessible without compromising on standards.

Understanding career prospects is crucial. For nurse practitioners with doctoral degrees, knowing how much do dnp nurses make can help set realistic financial goals and plan for future growth. Salaries vary by state and specialization, making this information valuable for career planning.

Finally, those looking to expand their scope might explore certification options such as acute care np certification. Transitioning from family nurse practitioner roles to acute care can enhance expertise and open new clinical opportunities in critical care settings.

Best Scientists Citing Hanneke Schuitemaker

Trending Scientists